Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené ze zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění vyhlášek č. 109/1997 Sb. a č. 131/1997 Sb

| 285.1 | J06BB | protiencefalický globulin | parent. | 1 | ML | 332,30 | K | | 95082 | FSME-BULIN I.M. | inj 1x1ml | IMM | A | | | | | 95083 | FSME-BULIN I.M. | inj 1x2ml | IMM | A | | | | | 95084 | FSME-BULIN I.M. | inj 1x5ml | IMM | A | | | | | 285.2 | J06BB01 | anti-d (rh) imunoglobulin (do 100 RG v jedné ampuli včetně) | parent. | 250 | RG | 1440,25 | K | | 93505 | RHEGA I.M.SEVAC | inj 1x1.75ml/100rg | SEV | CZ | | | | | 285.3 | J06BB01 | anti-d (rh) imunoglobulin (nad 100 RG v jedné ampuli) | parent. | 250 | RG | 1110,00 | K | | 80529 | HUMAN ANTI-D IMMUNEGLOB.GRIFOLS | inj sic 1x250rg+2ml | GFO | E | | | | | 02445 | RHEGA I.M.SEVAC | inj 1x2.5ml/250rg | SEV | CZ | | | | | 285.4 | J06BB02 | imunoglobulin proti tetanu | parent. | | | plně | B | | 80530 | HUMAN ANTITETANUS IMMMUNEGLOB. | inj sic 1x250ut+2ml | GFO | E | | | | | 80531 | HUMAN ANTITETANUS IMMMUNEGLOB. | inj sic 1x500ut+2ml | GFO | E | | | | | 83607 | TETABULIN | inj 250ut/ml | IMM | A | | | | | 88069 | TEGA IMUNA | inj 1x2ml/250ut | IMA | SK | | | | | 285.5 | J06BB03 | imunoglobulin proti neštovicím a pásovému oparu | parent. | 1 | KU | 34566,40 | K/P | | 97894 | VARITECT(R) | inj 1x5ml | BTP | D | | | | | 97895 | VARITECT(R) | inj 1x20ml | BTP | D | | | | | 97896 | VARITECT(R) | inj 1x50ml | BTP | D | | | | | 285.6 | J06BB04 | imunoglobulin proti hepatitidě B | parent. | | | plně | K | | 94265 | AUNATIV | inj 1x5ml | KBP | S | | | | | 97897 | HEPATECT(R) | inj 1x2ml | BTP | D | | | | | 97898 | HEPATECT(R) | inj 1x10ml | BTP | D | | | | | 285.7 | J06BB09 | imunoglobulin proti cytomegalovirové infekci | parent. | 1 | GM | 5070,55 | U/P | | 99646 | CMVVEGA I.V. | inj sic 500mg bilk. | IMA | SK | | | | | 94862 | CYTOTECT | inj 1x10ml 100mg/ml | BTP | D | | | | | 94863 | CYTOTECT | inj 1x20ml 100mg/ml | BTP | D | | | | | 94864 | CYTOTECT | inf 1x50ml 100mg/ml | BTP | D | | | | | 286 | J07AM | očkovací látky proti tetanu | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 286.1 | J07AM01 | tetanový toxoid | parent. | | | plně | K | | 69795 | ALTEANA S IMUNA | inj 10x0.5ml | IMA | SK | | | | | 69796 | ALTEANA S IMUNA | inj 10x1ml | IMA | SK | | | | | 69797 | ALTEANA S IMUNA | inj 10x5ml | IMA | SK | | | | | 69798 | ALTEANA S IMUNA | inj 50x0.5ml | IMA | SK | | | | | 69799 | ALTEANA S IMUNA | inj 50x1ml | IMA | SK | | | | | 83622 | ALTEANA SEVAC | inj 10x0.5ml | SEV | CZ | | | | | 83443 | TETAVAX | inj 1x0.5ml-strik. | PMX | F | | | | | 83444 | TETAVAX | inj 20x0.5ml-strik. | PMX | F | | | | | 83445 | TETAVAX | inj 1x10ml. | PMX | F | | | | | 83447 | TETAVAX | inj 10x20ml | PMX | F | | | | | 83525 | TETAVAX | inj 20x0.5ml-ampule | PMX | F | | | | | 83526 | TETAVAX | inj 10x10ml | PMX | F | | | | | 287 | J07AN | očkovací látky proti tuberkulóze | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 287.1 | J07AN01 | tuberkulosa, živé atenuované mykobakterium | parent. | 1 | DF | 183,00 | H | | 66857 | BCG-VACCINE 500 BEHRING | lyo 50x0.1ml+50ml | BEH | A | | | | | 76189 | BCG-VACCINE 500 BEHRING | lyo 50x0.1ml+50ml | BEH | D | | | | | 76027 | LYOPHILIZED B.C.G.VACCINE | lyo 10x10davek+sol. | PMX | F | | | | | 76028 | LYOPHILIZED B.C.G.VACCINE | lyo 10x20davek+sol. | PMX | F | | | | | 288 | J07AX | jiné bakteriální očkovací látky | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 288.1 | J07AX | jiné bakteriální vakcíny (protistafylokoková vakcína) | parent. | | | plně | K | | 94269 | POLYSTAFANA SEVAC | inj 10x0.5ml | SEV | CZ | | | | | 288.2 | J07AX | jiné bakteriální vakcíny (směs bakterinů) | parent. | 1 | DF | 26,75 | K | | 01212 | ADNEXBA SEVAC S.C. | inj 12x0.5ml | SEV | CZ | | | | | 288.3 | J07AX | jiné bakteriální vakcíny (protipseudomonádová vakcina) | parent. | 1 | DF | 210,75 | K | | 07388 | PSAEVA SEVAC VACC.PSEUDOMONAE | inj 10x0.3ml | SEV | CZ | | | | | 289 | J07BG | očkovací látky proti vzteklině | parent. | K | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | | | plně | K | | 66854 | MERIEUX INACTIVAT.RABIES VACC. | lyo 1davka+1ml solv | PMX | F | | | | | 75379 | RABIPUR (PCEC RABIES VACCINE) | inj sic 1x2.5ut+1ml | BEH | D | | | | | 90996 | RABIPUR (PCEC RABIES VACCINE) | inj sic 5x2.5ut+1ml | BEH | D | | | | | 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F | | | | | 290 | L01AA | alkylační cytostatika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,85 | | | 94174 | CYCLOPHOSPHAMID | tbl 50x50mg | FAO | SF | | | | | 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,60 | | | | | | | | | | | | 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,80 | | | | | | | | | | | | 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,40 | | | 02050 | ALKERAN | tbl obd 25x2mg | BWE | GB | | | | | 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,95 | | | | | | | | | | | | 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,70 | | | 291 | L01AA | alkylační cytostatika | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,85 | B | | 94546 | CYCLOPHOSPHAMIDE 200MG | inj 10x200mg | FAO | SF | | | | | 87127 | ENDOXAN | inj sic 1x500mg | ASD | D | | | | | 87128 | ENDOXAN | inj sic 1x1gm | ASD | D | | | | | 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,90 | B/ONK,HEM | | 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 35,00 | B/ONK,HEM | | | | | | | | | | | 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,65 | B/ONK,HEM | | 44000 | HOLOXAN 200MG | inj sic 10x200mg | ASD | D | | | | | 70467 | HOLOXAN 500MG | inj sic 1x500mg | ASD | D | | | | | 291.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1 | MG | 1,45 | B/ONK,HEM | | 70468 | HOLOXAN 1GM | inj sic 1x1gm | ASD | D | | | | | 70469 | HOLOXAN 2GM | inj sic 1x2gm | ASD | D | | | | | 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,80 | B/ONK,HEM | | 292 | L01AB | alkylsulfaty | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 15,20 | L/ONK,HEM | | 93587 | MYLERAN | tbl 25x0.5mg | BWE | GB | | | | | 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 | MG | 5,00 | L/ONK,HEM | | 21157 | MYLERAN | tbl 100x2mg | BWE | GB | | | | | 293 | L01AD | nitrosomočoviny | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,85 | L/ONK,HEM | | 60270 | CEENU LOMUSTINE (CCNU) | cps 20x10mg | BMS | USA | | | | | 293.2 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,55 | L/ONK,HEM | | 60272 | CEENU LOMUSTINE (CCNU) | cps 20x100mg | BMS | USA | | | | | 293.3 | L01AD02 | lomustin (od 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 | MG | 6,15 | L/ONK,HEM | | 03735 | LOMUSTINE | cps 6 | BMS | USA | | | | | 60271 | CEENU LOMUSTINE (CCNU) | cps 20x40mg | BMS | USA | | | | | 294 | L01AD | nitrosomočoviny | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 294.1 | L01AD01 | karmustin | parent. | 1 | MG | 10,15 | B/ONK,HEM | | 80470 | BICNU (CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | D | | | | | 83482 | BICNU (CARMUSTINE FOR I.V.-BCNU) | inj sic 1x100mg+3ml | BMS | USA | | | | | 294.2 | L01AD04 | streptozocin | parent. | 10 | MG | 15,15 | B/ONK,HEM | | 295 | L01BA | antimetabolity ze skupiny analog kyseliny listové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 295.1 | L01BA01 | metotrexát | p.o. | 1 | MG | 1,20 | | | 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | LCM | CZ | | | | | 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | | | 296 | L01BA | antimetabolity ze skupiny analog kyseliny listové | parent. | B | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 8,85 | B | | 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ | | | | | 296.2 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,75 | B | | 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ | | | | | 296.3 | L01BA01 | metotrexát (od 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,15 | B | | 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ | | | | | 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ | | | | | 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ | | | | | 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ | | | | | 83484 | METHOTREXAT LEDERLE | inf 1x20ml/500mg | LED | D | | | | | 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 6,35 | L/ONK,HEM | | 94241 | PURI-NETHOL | tbl 25x50mg | BWE | GB | | | | | 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9,55 | L/ONK,HEM | | 03736 | LANVIS | tbl 25x40mg | BWE | GB | | | | | 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 1199,00 | B/ONK,HEM | | 44013 | LEUSTATIN | inj 1x10ml/10mg | OBI | USA | | | | | 44014 | LEUSTATIN | inj 7x10ml/10mg | OBI | USA | | | | | 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 139,20 | B/ONK,HEM | | 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG | D | | | | | 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,70 | L/ONK,HEM | | | | | | | | | | | 299.2 | L01BC02 | fluorouracil | p.o. | 10 | MG | 1,45 | L/ONK,HEM | | 10407 | FTORAFUR | cps 100x400mg | MDX | SU | | | | | 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,30 | B/ONK,HEM | | 02532 | ALEXAN (AMPULE) | inj 30x2ml/40mg | MAC | D | | | | | 87829 | ALEXAN (AMPULE) | inj 10x5ml/100mg | MAC | D | | | | | 99483 | ALEXAN (LAHVICKY) | inj 10x5ml/100mg | MAC | D | | | | | 99484 | ALEXAN (LAHVICKY) | inj 30x2ml/40mg | MAC | D | | | | | 08796 | CYTOSAR 100MG | inj sic 1x100mg+5ml | UPJ | B | | | | | 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,10 | B/ONK,HEM | | 96990 | ALEXAN (LAHVICKY) | inj 1x20ml/1000mg | MAC | D | | | | | 62814 | ALEXAN 1000MG AD INFUS. | inf 1x20ml | MAC | D | | | | | 85837 | CYTOSAR 500MG | inj sic 500mg+10ml | UPJ | B | | | | | 65423 | CYTOSAR 1GM | inj sic 1x1000mg | UPJ | B | | | | | 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,90 | B/ONK,HEM | | 84119 | 5-FU LEDERLE | inj 1x20ml/1gm | LED | D | | | | | 86070 | FLUORO-URACIL | inj 5x5ml/250mg | HLR | CH | | | | | 300.4 | L01BC05 | gemcitabin | parent. | 1 | MG | 6,30 | B/ONK,HEM | | 84335 | GEMZAR 200MG | inj sic 1x200mg | LIL | F | | | | | 84336 | GEMZAR 1GM | inj sic 1x1gm | LIL | F | | | | | 301 | L01CA | vinka alkaloidy a jejich deriváty | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 27,15 | B/ONK,HEM | | 85518 | VELBE | inj sic 1x10mg | LIL | F | | | | | 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 186,80 | B/ONK,HEM | | 74990 | CITOMID 1MG | inj sic 1x1mg+10ml | LMR | MEX | | | | | 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 110,75 | B/ONK,HEM | | 98203 | NAVELBINE | inj 10x5ml/50mg | PFB | F | | | | | 302 | L01CB | podofylotoxinové deriváty | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 302.1 | L01CB01 | etoposid | p.o. | 1 | MG | 4,00 | L/ONK,HEM | | 86416 | VEPESID | cps 20x50mg | BMS | D | | | | | 86417 | VEPESID | cps 10x100mg | BMS | D | | | | | 303 | L01CB | podofylotoxinové deriváty | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 4,25 | B/ONK,HEM | | 78088 | ETOPOSIDE PIERRE FABRE | inj 5x5ml/100mg | PFB | F | | | | | 86418 | VEPESID | inj 10x5ml/100mg | BMS | D | | | | | 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,45 | B/ONK,HEM | | 86409 | VUMON | inj 10x5ml/50mg | BMS | D | | | | | 304 | L01CD | taxany | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 191,30 | X | | 44134 | TAXOL | inj 1x17ml/100mg | BMS | I | | | | | 76204 | TAXOL | inj 1x5ml/30mg | BMS | I | | | | | 92494 | TAXOL | inj 10x5ml/30mg | BMS | I | | | | | 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 387,60 | X | | 56479 | TAXOTERE 20MG | inf 0.5ml/20mg+solv | RRO | CND | | | | | 85984 | TAXOTERE 20MG | inf 0.5ml/20mg+solv | RRO | F | | | | | 92742 | TAXOTERE 20MG | inf 0.5ml/20mg+solv | RRO | GB | | | | | 56480 | TAXOTERE 80MG | inf 2ml/80mg+solv | RRO | CND | | | | | 85985 | TAXOTERE 80MG | inf 2ml/80mg+solv | RRO | F | | | | | 92743 | TAXOTERE 80MG | inf 2ml/80mg+solv | RRO | GB | | | | | 305 | L01DA | aktinomyciny | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 305.1 | L01DA01 | daktinomycin | parent. | 1 | MG | 680,10 | B/ONK,HEM | | 21055 | LYOVAC COSMEGEN | inj sic 1x0.5mg | MSD | USA | | | | | 306 | L01DB | antracykliny a jejich deriváty | p.o. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 303,40 | X | | 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I | | | | | 78813 | ZAVEDOS 10MG | cps 1x10mg | FAR | I | | | | | 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I | | | | | 307 | L01DB | antracykliny a jejich deriváty | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 307.1 | L01DB01 | doxorubicin | parent. | 1 | MG | 39,70 | B/ONK,HEM | | 94567 | RASTOCIN | inj 10x10mg | PLI | CHO | | | | | 307.2 | L01DB02 | daunorubicin | parent. | 1 | MG | 21,45 | B/ONK,HEM | | 96122 | DAUNOBLASTINA | inj sic. 1/20mg+sol | FAR | I | | | | | 307.3 | L01DB03 | epirubicin | parent. | 1 | MG | 47,90 | B/ONK,HEM | | 94373 | FARMORUBICIN RAPID DISSOLUTION | inj 1x50mg | PHA | I | | | | | 307.4 | L01DB04 | aklarubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM | | | | | | | | | | | 307.5 | L01DB05 | zorubicin | parent. | 1 | MG | 19,65 | B/ONK,HEM | | | | | | | | | | | 307.6 | L01DB06 | idarubicin | parent. | 1 | MG | 770,85 | B/ONK,HEM | | | | | | | | | | | 307.7 | L01DB07 | mitoxantron | parent. | 1 | MG | 40,00 | B/ONK,HEM | | 94831 | REFADOR | inj 1x15ml 2mg/ml | SPX | CZ | | | | | 308 | L01DC | ostatní cytotoxická antibiotika | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 59,25 | B/ONK,HEM | | 03404 | BLEOCIN | inj 1x15mg | NKU | J | | | | | 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 86,60 | B/ONK,HEM | | 10630 | MITOMYCIN C KYOWA | inj sic 10x2mg | KYA | J | | | | | 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 69,30 | B/ONK,HEM | | 83440 | MITOMYCIN C KYOWA | inj sic 5x20mg | KYA | J | | | | | 309 | L01XA | platinová cytostatika | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 309.1 | L01XA01 | cisplatina | parent. | 1 | MG | 8,00 | B/ONK,HEM | | 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ | | | | | 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ | | | | | 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ | | | | | 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | MG | 6,35 | B/ONK,HEM | | 75010 | CYCLOPLATIN | inj 1x5ml/50mg | LCM | CZ | | | | | 90777 | CYCLOPLATIN 50 | inj sic 10x50mg | LCM | CZ | | | | | 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 4,00 | B/ONK,HEM | | 75011 | CYCLOPLATIN | inj 1x15ml/150mg | LCM | CZ | | | | | 75012 | CYCLOPLATIN | inj 1x45ml/450mg | LCM | CZ | | | | | 60924 | CYCLOPLATIN | inj 1x60ml/600mg | LCM | CZ | | | | | 93665 | CYCLOPLATIN 200 | inj sic 5x200mg | LCM | CZ | | | | | 310 | L01XB | methylhydrazinová cytostatika | p.o. | L/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2,50 | L/ONK,HEM | | 01814 | NATULAN | cps 50x50mg | HLR | CH | | | | | 311 | L01XX | ostatní cytostatika | p.o. | L/ONK,HEM,URN | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 311.1 | L01XX05 | hydroxy-močovina | p.o. | 0.1 | GM | 2,35 | L/ONK,HEM, URN | | 95122 | LITALIR | cps 100x500mg | BMS | D | | | | | 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 4,10 | L/ONK,HEM, URN | | 08921 | ESTRACYT | cps 100x140mg | KBP | S | | | | | 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 107,25 | L/ONK,HEM, URN | | 84009 | VESANOID | cps 100x10mg | HLR | CH | | | | | 312 | L01XX | ostatní cytostatika | parent. | B/ONK,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu L-asparaginázou ordinuje onkolog nebo hematolog. Revizní lékař pojišťovny může na základě žádosti lékaře povolit plnou úhradu ekonomicky náročnějších přípravků obsahujících L-asparaginázu v případě, že se jedná o podání dětem do 18 let věku, nebo že se jedná o opakované podání starším osobám, případně u pacientů s alergickou anamnézou.

| 312.1 | L01XX01 | amsakrin | parent. | 1 | MG | 29,00 | B/ONK,HEM | | 93503 | AMSIDYL | inj 6x85mg/1.7ml+so | GOD | D | | | | | 312.2 | L01XX02 asparagináza | parent. | 1 | MG | 2848,40 | B/P | | | 94058 | ERWINASE | inj sic 20x10ku | POT | GB | | | | | 92117 | KIDROLASE | inj sic 10x10ku | RBE | F | | | | | 312.3 | L01XX11 | estramustin | parent. | 1 | MG | 1,30 | B/ONK,HEM, URN | | 40624 | ESTRACYT 300MG | inj sic 10x300mg+sol | PHA | S | | | | | 312.4 | L01XX13 | dakarbazin | parent. | 10 | MG | 8,10 | B/ONK,HEM | | 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ | | | | | 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ | | | | | 312.5 | L01XX17 | topotekan | parent. | 1 | MG | 3136,70 | X | | 313 | L02AA | estrogeny | p.o. | L/ONK,HEM,URN,GYN, SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,40 | L/ONK,HEM, URN GYN,SEX | | | | | | | | | | | 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,15 | L/ONK,HEM, URN GYN,SEX | | 87548 | TURISTERON | drg 21x1mg | VJP | D | | | | | 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,40 | L/ONK,HEM, URN GYN,SEX | | 314 | L02AA | estrogeny | parent. | B/ONK,HEM,URN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 314.1 | L02AA | polyestradioli phosphas | parent. | 1 | MG | 3,55 | B/ONK,HEM, URN,SEX | | 88381 | ESTRADURIN | inj sic 10x80mg+2ml | KBP | S | | | | | 314.2 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,70 | B/ONK,HEM, URN,SEX | | | | | | | | | | | 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,90 | B/ONK,HEM, URN,SEX | | 315 | L02AB | progestiny | p.o. | L/ONK,HEM,URN,GYN, SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 315.1 | L02AB01 | megestrol | p.o. | 10 | MG | 3,15 | L/ONK,HEM, URN GYN,SEX | | 86059 | MEGACE | tbl | 100x160mg | BMS | D | | | | 86211 | MEGACE | tbl | 100x40mg | BMS | D | | | | 315.2 | L02AB02 | medroxy-progesteron | p.o. | 10 | MG | 2,00 | L/ONK,HEM, URN GYN,SEX | | 88429 | FARLUTAL | tbl 30x500mg | FAR | I | | | | | 91618 | PROVERA | tbl 20x500mg | UPJ | GB | | | | | 316 | L02AB | progestiny | parent. | L/ONK,GYN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 316.1 | L02AB02 | medroxy-progesteron | parent. | 10 | MG | 3,35 | L/ONK,GYN, SEX | | 90993 | DEPO-PROVERA 500 | inj 1x3.3ml/500mg | UPJ | B | | | | | 85678 | FARLUTAL DEPOT | inj 1x2.5ml/500mg | PHA | I | | | | | 316.2 | L02AB03 | gestonoron | parent. | 1 | MG | 1,15 | L/ONK,GYN, SEX | | 317 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | inhal. | Z | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 317.1 | L02AE01 | buserelin | inhal. | 1 | MG | 229,85 | Z | | 90966 | SUPREFACT NASAL | sol nas 4x10gm/10mg | HOE | D | | | | | 318 | L02AE | hormon uvolňující gonadotrofin a jeho deriváty | parent. | K/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje onkolog, urolog nebo gynekolog:

• a) léčba karcinomu prsní žlázy u premenopauzálních a perimenopauzálních žen, jen po dobu adjuvantní chemo- nebo radioterapie.

• b) léčba karcinomu prostaty,

• c) léčba myomatózy spojené s poruchou fertility nebo její těžké formy vyžadující předoperační redukci nálezu,

• d) léčba těžkých, jinak konzervativně nereagujících forem endometriózy,

• e) pubertas precox,

• f) indukce ovulace při in vitro fertilizaci pouze na základě předchozího schválení revizním lékařem.

| 318.1 | L02AE01 | buserelin | parent. | 1 | MG | 273,65 | K/P | | 90961 | SUPREFACT | inj 2x5.5ml/5.5mg | HOE | D | | | | | 318.2 | L02AE01 | buserelin (depotní lékové formy) | parent. | 1 | MG | 2077,15 | K/P | | 75018 | SUPREFACT DEPOT | imp 2x3.3mg+aplik. | HOE | D | | | | | 318.3 | L02AE02 | leuprorelin | parent. | 1 | MG | 273,65 | K/P | | | | | | | | | | | 318.4 | L02AE02 | leuprorelin (depotní lékové formy) | parent. | 1 | MG | 1852,35 | K/P | | 76553 | LUCRIN DEPOT 3.75MG | inj sic 1+solv+str. | ABB | E | | | | | 318.5 | L02AE03 | goserelin (depotní lékové formy) | parent. | 1 | MG | 1944,45 | K/P | | 12320 | ZOLADEX 10.8MG DEPOT | inj 1x10.8mg | ZNC | GB | | | | | 65386 | ZOLADEX DEPOT | inj 1x3.6mg | ZNC | GB | | | | | 318.6 | L02AE04 | triptorelin | parent. | 1 | MG | 273,65 | K/P | | | | | | | | | | | 318.7 | L02AE04 | triptorelin (depotní lékové formy) | parent. | 1 | MG | 1901,50 | K/P | | 96107 | DECAPEPTYL DEPOT | inj sic 3.75mg+2ml | FEI | D | | | | | 319 | L02BA | antiestrogeny | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 319.1 | L02BA01 | tamoxifen | p.o. | 10 | MG | 3,45 | | | 67039 | TAMIFEN 10 | tbl 30x10mg | MOE | CY | | | | | 44056 | TAMOXIFEN EBEWE 10 | tbl 30x10mg | EBW | A | | | | | 44057 | TAMOXIFEN EBEWE 20 | tbl 30x20mg | EBW | A | | | | | 44058 | TAMOXIFEN EBEWE 30 | tbl 30x30mg | EBW | A | | | | | 44059 | TAMOXIFEN EBEWE 40 | tbl 30x40mg | EBW | A | | | | | 88392 | TAMOXIFEN LACHEMA 10 | tbl 100x10mg | LCM | CZ | | | | | 71958 | ZITAZONIUM 10MG | tbl 30x10mg | EGI | H | | | | | 71959 | ZITAZONIUM 10MG | tbl 10x10mg | EGI | H | | | | | 31243 | ZITAZONIUM 20MG | tbl 60x20mg | EGI | H | | | | | 44144 | ZITAZONIUM 20MG | tbl 30x20mg | EGI | H | | | | | 44146 | ZITAZONIUM 30MG | tbl 30x30mg | EGI | H | | | | | 31384 | ZITAZONIUM 40MG | tbl 30x40mg | EGI | H | | | | | 320 | L02BB | antiandrogeny | p.o. | L/ONK,URN,SEX | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 320.1 | L02BB01 | flutamid | p.o. | 10 | MG | 1,35 | L/ONK,URN, SEX | | 55953 | FLUTACAN 250MG | tbl 100x250mg | LOY | SF | | | | | 320.2 | L02BB02 | nilutamid | p.o. | 1 | MG | 0,70 | L/ONK,URN, SEX | | 94820 | ANANDRON | tbl 90x50mg | ROU | F | | | | | 320.3 | L02BB03 | bicalutamid | p.o. | 50 | MG | 101,25 | L/ONK,URN, SEX | | 321 | L02BG | inhibitory tvorby steroidních hormonů | p.o. | L/ONK,END | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 321.1 | L02BG01 | aminogluthetimid | p.o. | 10 | MG | 0,70 | L/ONK,END | | 07510 | ORIMETEN | tbl 100x250mg | CGC | CH | | | | | 322 | L02BG | inhibitory tvorby steroidních hormonů | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 322.1 | L02BG02 | formestan | parent. | 250 | MG | 4103,40 | X | | 92361 | LENTARON DEPOT 250MG I.M. | inj sic 1x250mg+2ml | CGC | CH | | | | | 323 | L03AA | cytokiny | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 323.1 | L03AA01 | interleukin 2 | parent. | 1 | MG | 8006,85 | X | | | | | | | | | | | 323.2 | L03AA02 | filgrastim | parent. | 1 | MG | 14664,95 | X | | 69026 | NEUPOGEN | inj 5x1ml | HLR | CH | | | | | 98297 | NEUPOGEN | inj 5x1.6ml | HLR | CH | | | | | 323.3 | L03AA03 | molgramostim | parent. | 1 | MG | 15801,45 | X | | 72549 | LEUCOMAX | inj sic 0.3mg+1ml | SAN | CH | | | | | 96865 | LEUCOMAX | inj sic 0.15mg+1ml | SAN | CH | | | | | 96866 | LEUCOMAX | inj sic 0.4mg+1ml | SAN | CH | | | | | 323.4 | L03AA10 | lenograstim | parent. | 1 | MG | 18193,20 | X | | 12953 | GRANOCYTE 34 | lyo 5x33.6mu+solv. | RRO | F | | | | | 323.5 | L03AA04 | interferon alfa | parent. | 1 | MU | 263,45 | X | | 76997 | ALPHAFERON 3MU | lyo 1x3mu+solv. | CFD | KOR | | | | | 80514 | HEBERON ALFA R | inj sic 1x3mu | HBC | C | | | | | 83942 | HEBERON ALFA R | inj sic 25x3mu | HBC | C | | | | | 89225 | ROFERON A | inj 1x3ml/18mu | HLR | CH | | | | | 25776 | WELLFERON | inj 1x1ml/5mu | BWE | GB | | | | | 93101 | WELLFERON | inj 1x1ml/10mu | BWE | GB | | | | | 323.6 | L03AA08 | interferon gamma | parent. | 1 | MU | 1566,45 | X | | 70481 | IMUKIN | inj 6x0.5ml/0.1mg | BOE | D | | | | | 86712 | IMUKIN | inj 6x0.5ml/0.1mg | BNE | A | | | | | 323.7 | L03AA11 | interferon beta | parent. | 1 | MU | 330,15 | X | | 87312 | BETAFERON | inj sic 15+15x2ml | SAG | D | | | | | 324 | L03AX | ostatní imunostimulační léčiva | lok., p.o. | L/ALG | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 324.1 | L03AX | směs bakteriálních lyzátů | lok. | 1 | BA | 75% | L/ALG | | | | | | | | | | | 324.2 | L03AX | směs bakteriálních lyzátů | p.o. | 1 | BA | 75% | | | | | | | | | | | | 324.3 | L03AX | vaccin. staphyl. phagolys. | lok. | 1 | ML | 37,35 | L/ALG | | 94631 | STAVA-NASAL | gtt 10x5ml | BIU | CZ | | | | | 325 | L03AX | ostatní imunostimulační léčiva | parent. | O | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 325.1 | L03A | dialyzát leukocytů | parent. | 1 | DF | 1011,05 | O/ALG,IMU | | 56930 | IMMODIN SEVAC | inj sic 1x2ml+solv. | SEV | CZ | | | | | 97146 | IMMODIN SEVAC | inj sic 5x2ml+solv. | SEV | CZ | | | | | 325.2 | L03A | thymostimulin | parent. | 1 | MG | 42,60 | Z | | 69041 | TP-1 SERONO | inj sic 1x50mg+sol | SRO | CH | | | | | 325.3 | L03AX | bac. propionibacterii acnes | parent. | 1 | MG | 74,50 | O/ONK | | 97886 | CORYNEBACTERIUM PARVUM | inj lyo 1x7mg | SVY | CZ | | | | | 325.4 | L03AX | laktobacillus acidophilus | parent. | 3 | DF | 639,80 | O/GYN | | 86711 | SOLCOTRICHOVAC | inj 3x0.5ml | SOC | CH | | | | | 325.5 | L03AX | vaccin. staphyl. phagolys. | parent. | 1 | DF | 74,65 | O | | 94026 | STAVA | inj 10x2ml | BIU | CZ | | | | | 325.6 | L03AX03 | BCG vakcína | parent. | 1 | MG | 44,35 | O/ONK,URN | | 68908 | IMMUCYST BCG IMMUNOTHERAPEUT. | inj sic 3x27mg+1ml | CNG | CND | | | | | 326 | L04AA | selektivní imunosupresivní léčiva | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu cyklosporinem ordinuje lékař pracující v transplantačních centrech, onkolog, hematolog, dermatolog, urolog a revmatolog:

• a) prevence reakce štěpu proti hostiteli po transplatnacích,

• b) léčba myelodysplaastického sysndromu nereagující na standardní léčbu,

• c) léčba aplastické anemie nereagující na standardní léčbu,

• d) léčba autoimunní hemolytické anemie a autoimunní trombocytopenické purpury nereagující na standardní léčbu,

• e) léčba nefrotického syndromu nereagující na standardní léčbu,

• f) těžké formy revmatoidní artritidy dospělých a dětí se středně těžkým a těžkým průběhem kloubního postižení nebo se současným postižením jiných orgánů (zvláště plic),

• g) těžké generalizované formy psoriázy (psoriasis vulgaris, arthropatica, pustulosa) nereagující na standardní léčbu,

• h) systémový lupus erythematodes nereagující na standardní léčbu,

• i) těžké formy polymyositidy/dermatomyositidy nereagující na standardní léčbu.

Léčba se zahajuje obvykle v rámci hospitalizace pacienta s odpovídajícím odstupem od jiné terapie (např. PUVA, retinoidy, cytostatika), léčbu provádí pouze pracoviště s dostupností příslušných laboratorních vyšetření (včetně stanovení hladiny cyklosporinu).

Léčbu mophetil mycophenolatem ordinuje lékař pracující v transplantačních centrech v indikaci profylaxe rejekce štěpu proti hostiteli pouze u pacientů u kterých byla provedena alogenní transplantace ledvin. Podává se v kombinaci s cyklosporinem a kortikosteroidy.

| 326.1 | L04AA01 | cyklosporin | p.o. | 1 | MG | 1,40 | P | | 94052 | CONSUPREN | sol 1x50ml 100mg/ml | GNO | CZ | | | | | 92572 | CONSUPREN 25MG | cps 50x25mg | GNO | CZ | | | | | 92573 | CONSUPREN 50MG | cps 50x50mg | GNO | CZ | | | | | 92574 | CONSUPREN 100MG | cps 50x100mg | GNO | CZ | | | | | 84044 | SANDIMMUN NEORAL 25MG | cps 50x25mg | SAN | CH | | | | | 84045 | SANDIMMUN NEORAL 50MG | cps 50x50mg | SAN | CH | | | | | 84046 | SANDIMMUN NEORAL 100MG | cps 50x100mg | SAN | CH | | | | | 84047 | SANDIMMUN NEORAL 100MG/ML | sol 1x50ml 100mg/ml | SAN | CH | | | | | 326.2 | L04AA06 | mophetil mycophenolát | p.o. | 10 | MG | 2,70 | P | | 55681 | CELLCEPT | cps 100x250mg | HLR | CH | | | | | 327 | L04AA | selektivní imunosupresivní léčiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 327.1 | L04AA | antilymfocytární IG | parent. | 10 | MG | 106,25 | U/J10 | | 88460 | ATG-FRESENIUS | inj 1x5ml/100mg | FRE | D | | | | | 88461 | ATG-FRESENIUS | inj 1x10ml/200mg | FRE | D | | | | | 327.2 | L04AA | antithymocytární IG | parent. | 1 | MG | 124,25 | U/J10 | | 91244 | THYMOGLOBULINE | inj sic 1x25mg+5ml | PMX | F | | | | | 327.3 | L04AA01 | cyklosporin | parent. | 1 | MG | 2,70 | U/J10 | | 88514 | SANDIMMUN KONZENTRAT | inf 10x5ml 50mg/1ml | SAN | CH | | | | | 95041 | SANDIMMUN KONZENTRAT | inf 10x1ml 50mg/1ml | SAN | CH | | | | | 327.4 | L04AA02 | muromonab-CD3 | parent. | 1 | MG | 1250,00 | U/J10 | | 96997 | CEDETRIN-T (MONOK.PROTIL.A1-CD3) | inj 10x3.2ml | EXB | CZ | | | | | 328 | L04AX | ostatní imunosupresiva | p.o. | L/J10,REV,HEM | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 328.1 | L04AX01 | azathioprin (do 25 mg v jedné tabletě včetně) | p.o. | 10 | MG | 1,60 | L/J10,REV, HEM NEU, OPH,DER | | 31396 | IMURAN | tbl obd 100x25mg | BWE | GB | | | | | 328.2 | L04AX01 | azathioprin (nad 25 mg v jedné tabletě) | p.o. | 10 | MG | 1,15 | L/J10,REV, HEM NEU, POH,DER | | 02418 | IMURAN | tbl obd 100x50mg | BWE | GB | | | | | 329 | L04AX | ostatní imunosupresiva | parent. | U/J10 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 329.1 | L04AX01 | azathioprin | parent. | 1 | MG | 10,05 | U/J10 | | 02016 | IMURAN | inj sic 1x50mg+2ml | BWE | GB | | | | | 330 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 330.1 | M01AA | butylpyrazolidiny | p.o. | 3 | DF | 3,40 | | | 00179 | KETAZON | drg 20x250mg | LEX | CZ | | | | | 330.2 | M01AA05 | klofezon | p.o. | 0.6 | GM | 3,40 | | | 331 | M01AA | protizánětlivá léčiva ze skupiny butylpyrazolidinů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 331.1 | M01AA | butylpyrazolidiny | parent. | 1 | DF | 7,05 | | | 00490 | KETAZON | inj 5x5ml/1gm | LEX | CZ | | | | | 332 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 332.1 | M01AB | deriváty kyseliny octové | p.o. | 70 | MG | 1,80 | | | 88917 | REPANIDAL | cps 30x35mg | LEX | CZ | | | | | 332.2 | M01AB01 | indometacin | p.o. | 0.1 | GM | 3,00 | | | 77078 | APO-INDOMETHACIN 50MG | cps 100x50mg | APT | CND | | | | | 97713 | APO-INDOMETHACIN 25MG | cps 100x25mg | APT | CND | | | | | 67403 | INDOBENE 50MG | cps 20x50mg | MCK | D | | | | | 67404 | INDOBENE 50MG | cps 50x50mg | MCK | D | | | | | 02630 | INDREN | cps 30x25mg | LEX | CZ | | | | | 332.3 | M01AB02 | sulindac | p.o. | 0.4 | GM | 5,20 | | | | | | | | | | | | 332.4 | M01AB03 | tolmetin | p.o. | 0.7 | GM | 5,20 | | | | | | | | | | | | 332.5 | M01AB05 | diklofenak | p.o. | 0.1 | GM | 5,20 | | | 96740 | APO-DICLO 25MG | tbl ent 100x25mg | APT | CND | | | | | 96742 | APO-DICLO 50MG | tbl ent 100x50mg | APT | CND | | | | | 55586 | DICLOFENAC 25 LECIVA | tbl obd 30x25mg | LEX | CZ | | | | | 67277 | DICLOFENAC 50 STADA | tbl obd 20x50mg | STD | D | | | | | 67278 | DICLOFENAC 50 STADA | tbl obd 50x50mg | STD | D | | | | | 67279 | DICLOFENAC 50 STADA | tbl obd 100x50mg | STD | D | | | | | 83764 | DICLOFENAC 100 STADA RETARD | tbl ret 50x100mg | STD | D | | | | | 92487 | DICLOFENAC 100 STADA RETARD | tbl ret 20x100mg | STD | D | | | | | 92488 | DICLOFENAC 100 STADA RETARD | tbl ret 100x100mg | STD | D | | | | | 89024 | DICLOFENAC AL 50 | tbl obd 20x50mg | APA | D | | | | | 89025 | DICLOFENAC AL 50 | tbl obd 50x50mg | APA | D | | | | | 89026 | DICLOFENAC AL 50 | tbl obd 100x50mg | APA | D | | | | | 75631 | DICLOFENAC AL RETARD | tbl obd 20x100mg | APA | D | | | | | 75632 | DICLOFENAC AL RETARD | tbl obd 50x100mg | APA | D | | | | | 75633 | DICLOFENAC AL RETARD | tbl obd 100x100mg | APA | D | | | | | 97596 | DICLOREUM | tbl ret 20x100mg | ASW | I | | | | | 97599 | DICLOREUM | tbl obd 30x50mg | ASW | I | | | | | 66954 | MONOFLAM 25MG | tbl obd 100x25mg | LIC | D | | | | | 66951 | MONOFLAM 50MG | tbl obd 20x50mg | LIC | D | | | | | 66953 | MONOFLAM 50MG | tbl obd 50x50mg | LIC | D | | | | | 66955 | MONOFLAM 50MG | tbl obd 100x50mg | LIC | D | | | | | 67505 | MONOFLAM RETARD | cps ret 20x100mg | LIC | D | | | | | 67506 | MONOFLAM RETARD | cps ret 50x100mg | LIC | D | | | | | 67507 | MONOFLAM RETARD | cps ret 100x100mg | LIC | D | | | | | 96398 | OLFEN 25 | tbl obd 30x25mg | MHA | CH | | | | | 75461 | REWODINA RETARD | tbl obd 50x100mg | VAD | D | | | | | 75462 | REWODINA RETARD | tbl obd 100x100mg | VAD | D | | | | | 98144 | VERAL 25MG | tbl 30x25mg | SLO | SK | | | | | 83518 | VERAL 50MG | tbl ent 20x50mg | SLO | SK | | | | | 83519 | VERAL 50MG | tbl ent 50x50mg | SLO | SK | | | | | 332.6 | M01AB05 | diklofenak (draselná sůl) | p.o. | 0.1 | GM | 8,80 | | | | | | | | | | | | 332.7 | M01AB06 | alclofenak | p.o. | 1.25 | GM | 5,20 | | | | | | | | | | | | 332.8 | M01AB09 | lonazolak | p.o. | 0.6 | GM | 5,20 | | | | | | | | | | | | 332.9 | M01AB16 | aceklofenak | p.o. | 0.2 | GM | 5,20 | | | | | | | | | | | | 332.10 | M01AB55 | diklofenak/ misoprostol (na obsah diklofenaku) | p.o. | 0.1 | GM | 30,00 | Z | | 333 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 333.1 | M01AB01 | indometacin | p.rect. | 0.1 | GM | 3,15 | | | 96329 | INDOMETACIN | sup 10x100mg | BLU | CHO | | | | | 333.2 | M01AB03 | tolmetin | p.rect. | 0.7 | GM | 11,50 | | | | | | | | | | | | 333.3 | M01AB05 | diklofenak | p.rect. | 0.1 | GM | 11,50 | | | 91969 | DICLOBERL 50 | sup 10x50mg | BCE | D | | | | | 97631 | DICLOREUM | sup 10x50mg | ASW | I | | | | | 97632 | DICLOREUM | sup 10x100mg | ASW | I | | | | | 66956 | MONOFLAM 50MG | sup 10x50mg | LIC | D | | | | | 66957 | MONOFLAM 100MG | sup 10x100mg | LIC | D | | | | | 96402 | OLFEN 50 | cps rec 10x50mg | MHA | CH | | | | | 96403 | OLFEN 100 | cps rec 5x100mg | MHA | CH | | | | | 76912 | REWODINA 50 | sup 10x50mg | VAD | D | | | | | 76913 | REVODINA 100 | sup 10x100mg | VAD | D | | | | | 333.4 | M01AB09 | lonazolak | p.rect. | 0.6 | GM | 11,50 | | | 334 | M01AB | protizánětlivá léčiva ze skupiny derivátů kyseliny octové | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 334.1 | M01AB01 | indometacin | parent. | 0.1 | GM | 10,00 | | | | | | | | | | | | 334.2 | M01AB05 | diklofenak | parent. | 0.1 | GM | 13,20 | | | 76727 | DICLO 75 VON CT | inj 5x2ml/75mg | CTA | D | | | | | 76728 | DICLO 75 VON CT | inj 30x2ml/75mg | CTA | D | | | | | 94632 | VERAL | inj 5x3ml | LEX | CZ | | | | | 335 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 335.1 | M01AC01 | piroxikam | p.o. | 20 | MG | 2,55 | | | 97710 | APO-PIROXICAM 20 | cps 100x20mg | APT | CND | | | | | 97711 | APO-PIROXICAM 10 | cps 100x10mg | APT | CND | | | | | 71947 | ARTHREMIN 20 | cps 30x20mg | LEX | CZ | | | | | 91721 | ARTHREMIN 10 | cps 30x10mg | LEX | CZ | | | | | 67174 | PIROX 10 | tbl 20x10mg | CTA | D | | | | | 68581 | PIROX 10 | tbl 50x10mg | CTA | D | | | | | 67175 | PIROX 20 | tbl 20x20mg | CTA | D | | | | | 68582 | PIROX 20 | tbl 50x20mg | CTA | D | | | | | 335.2 | M01AC02 | tenoxikam | p.o. | 20 | MG | 2,55 | | | | | | | | | | | | 335.3 | M01AC06 | meloxikam | p.o. | 15 | MG | 8,80 | | | 336 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 336.1 | M01AC01 | piroxikam | p.rect. | 20 | MG | 11,50 | | | 67172 | PIROX 20 | sup 10x20mg | CTA | D | | | | | 67173 | PIROX 20 | sup 50x20mg | CTA | D | | | | | 336.2 | M01AC02 | tenoxikam | p.rect. | 20 | MG | 11,50 | | | | | | | | | | | | 336.3 | M01AC06 | meloxikam | p.rect. | 15 | MG | 11,50 | | | 337 | M01AC | protizánětlivá léčiva ze skupiny oxikamů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 337.1 | M01AC01 | piroxikam | parent. | 20 | MG | 12,10 | | | 67171 | PIROX 20 VON CT | inj 30x1ml/20mg | CTA | D | | | | | 89853 | PIROX 20 VON CT | inj 5x1ml/20mg | CTA | D | | | | | 337.2 | M01AC02 | tenoxikam | parent. | 20 | MG | 12,10 | | | 338 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 338.1 | M01AE01 | ibuprofen | p.o. | 1.2 | GM | 3,45 | | | 97989 | APO-IBUPROFEN 400MG | tbl 100x400mg | APT | CND | | | | | 83721 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 30x400mg | GNS | GB | | | | | 98321 | IBUPROFEN DH 400MG DIAG HUMAN | tbl obd 250x400mg | GNS | GB | | | | | 98324 | IBUPROFEN DH 600MG DIAG HUMAN | tbl obd 250x600mg | GNS | GB | | | | | 338.2 | M01AE01 | ibuprofen (lékové formy sirupu) | p.o. | 1.2 | GM | 20,00 | | | | | | | | | | | | 338.3 | M01AE02 | naproxen (pevné lékové formy) | p.o. | 0.5 | GM | 5,20 | | | | | | | | | | | | 338.4 | M01AE02 | naproxen (tekuté lékové formy) | p.o. | 0.5 | GM | 13,45 | | | 31373 | NAPROSYN | sus 1x100ml 25mg/ml | KRK | SLO | | | | | 338.5 | M01AE03 | ketoprofen | p.o. | 0.15 | GM | 5,20 | | | 76655 | KETONAL | cps 25x50mg | LEK | SLO | | | | | 76653 | KETONAL FORTE | tbl obd 20x100mg | LEK | SLO | | | | | 76654 | KETONAL RETARD | tbl ret 20x150mg | LEK | SLO | | | | | 338.6 | M01AE07 | suprofen | p.o. | 0.4 | GM | 5,20 | | | | | | | | | | | | 338.7 | M01AE08 | pirprofen | p.o. | 0.8 | GM | 5,20 | | | | | | | | | | | | 338.8 | M01AE09 | flurbiprofen | p.o. | 0.2 | GM | 5,20 | | | | | | | | | | | | 338.9 | M01AE10 | indoprofen | p.o. | 0.6 | GM | 5,20 | | | | | | | | | | | | 338.10 | M01AE11 | kyselina tiaprofenová | p.o. | 0.6 | GM | 8,80 | | | 96484 | SURGAM | tbl 20x300mg | LEX | CZ | | | | | 338.11 | M01AG02 | kyselina tolfenámová | p.o. | 0.3 | GM | 5,20 | | | 339 | M01AE | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové | p.rect. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 339.1 | M01AE01 | ibuprofen | p.rect. | 1.2 | GM | 11,50 | | | 67504 | IBUPROF VON CT | sup 10x500mg | CTA | D | | | | | 339.2 | M01AE02 | naproxen | p.rect. | 0.5 | GM | 11,50 | | | 67105 | NAPROXEN 250 VON CT | sup 10x250mg | CTA | D | | | | | 67107 | NAPROXEN 500 VON CT | sup 10x500mg | CTA | D | | | | | 339.3 | M01AE03 | ketoprofen | p.rect. | 0.15 | GM | 11,50 | | | 76652 | KETONAL | sup 12x100mg | LEK | SLO | | | | | 67639 | KETOPROFEN VON CT | sup 10x100mg | CTA | D | | | | | 67640 | KETOPROFEN VON CT | sup 50x100mg | CTA | D | | | | | 06171 | PROFENID 100MG | sup 12 | SPC | F | | | | | 339.4 | M01AE11 | kyselina tiaprofenová | p.rect. | 0.6 | GM | 11,50 | | | 340 | M01A | protizánětlivá léčiva ze skupiny derivátů kyseliny propionové a fenamátů | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 340.1 | M01AE01 | ibuprofen | parent. | 1.2 | GM | 20,20 | | | 340.2 | M01AE02 | naproxen | parent. | 0.5 | GM | 20,20 | | | 62598 | NAPROSYN | inj 5x5ml/500mg | KRK | SLO | | | | | 340.3 | M01AE03 | ketoprofen | parent. | 0.15 | GM | 20,20 | | | 76657 | KETONAL I.M. | inj 10x2ml/100mg | LEK | SLO | | | | | 340.4 | M01AG | etofenamat | parent. | 1 | GM | 20,20 | | | 341 | M01AX | ostatní protizánětlivá léčiva | p.o. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 341.1 | M01AX01 | nabumeton | p.o. | 1 | GM | 29,25 | L/REV | | 83731 | RELIFEX | tbl obd 20x500mg | LEX | CZ | | | | | 341.2 | M01AX04 | azapropazon | p.o. | 0.75 | GM | 5,20 | | | | | | | | | | | | 341.3 | M01AX05 | glukosamin sulfat | p.o. | 1.5 | GM | 11,70 | L/REV | | | | | | | | | | | 341.4 | M01AX13 | proquazon | p.o. | 0.9 | GM | 5,20 | | | | | | | | | | | | 341.5 | M01AX17 | nimesulid (pevné lékové formy) | p.o. | 0.2 | GM | 14,65 | L/REV | | | | | | | | | | | 341.6 | M01AX17 | nimesulid (tekuté lékové formy) | p.o. | 0.2 | GM | 20,00 | L/REV,PDD | | | | | | | | | | | 341.7 | M01AX17 | nimesulid | p.rect. | 0.2 | GM | 14,65 | L/REV | | 342 | M01CB | léčiva obsahující zlato | parent. | L/REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 342.1 | M01CB01 | aurothiomalát sodný | parent. | 2.4 | MG | 6,40 | L/REV | | 02780 | TAUREDON | inj 10x0.5ml/50mg | BGL | D | | | | | 02781 | TAUREDON | inj 10x0.5ml/20mg | BGL | D | | | | | 343 | M01C | penicilamin a ostatní chorobu modifikující léčiva včetně skupiny M09 | p.o., parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu kyselinou hyaluronovou ordinuje ortoped nebo revmatolog:

součást léčby primární osteoarthrózy kolenních klobů, rentgenologicky II. a III. stádium dle Kellgrena, při pravidelných bolestech větší intenzity, nebo u pacientů, u kterých je léčba nesteroidními antirevmatiky kontraindikována.

| 343.1 | M01CC01 | penicilamin (do 150 mg v jedné tabletě včetně) | p.o. | 0.5 | GM | 32,65 | | | 66755 | METALCAPTASE | tbl obd 50x150mg | KNO | D | | | | | 343.2 | M01CC01 | penicilamin (nad 150 mg v jedné tabletě) | p.o. | 0.5 | GM | 23,50 | | | 09738 | TROLOVOL | tbl obd 100x300mg | ASD | D | | | | | 92732 | TROLOVOL | tbl obd 50x300mg | ASD | D | | | | | 343.3 | M09AX01 | kyselina hyaluronová | parent. | 3.6 | MG | 200,00 | P | | | | | | | | | | | 343.4 | M09AX02 | chondroitin sulfat | p.o. | 1.6 | GM | 20,00 | L/REV | | 344 | M02AA | nesteroidní protizánětlivá léčiva k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 344.1 | M02AA | protizánětlivé přípr., nesteroidní, k zevnímu použití | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.2 | M02AA | ketofenylbutazon | lok. | 1 | GM | 1,00 | | | 00865 | KETAZON 10% | ung 1x20gm | LEX | CZ | | | | | 344.3 | M02AA05 | benzydamin | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.4 | M02AA06 | etofenamát | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.5 | M02AA07 | piroxikam | lok. | 1 | GM | 1,00 | | | 84448 | REUMADOR | gel 1x58gm | SLO | SK | | | | | 344.6 | M02AA10 | ketoprofen | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.7 | M02AA13 | ibuprofen | lok. | 1 | GM | 1,00 | | | 75289 | DOLGIT | crm 1x100gm/5gm | DLR | D | | | | | 344.8 | M02AA15 | diklofenak | lok. | 1 | GM | 1,00 | | | 70423 | ARTHREX CELLUGEL | gel 1x50gm | SGW | D | | | | | 55478 | DICLOFENAC LECIVA | gel 1x35gm 1% | LEX | CZ | | | | | 76910 | FLECTOR EP GEL | gel 1x60gm | IBS | CH | | | | | 76911 | FLECTOR EP GEL | gel 1x100gm | IBS | CH | | | | | 96397 | OLFEN | gel 50gm | MHA | CH | | | | | 76777 | VERAL | gel 1x55gm | SLO | SK | | | | | 344.9 | M02AA15 | diklofenak (transdermální lékové formy) | transd. | 2 | DF | 5,20 | | | | | | | | | | | | 344.10 | M02AA17 | kyselina niflumová | lok. | 1 | GM | 1,00 | | | 98246 | NIFLUGEL 2.5% | gel 1x60gm 2.5% | UPS | F | | | | | 98244 | NIFLURIL | crm 1x60gm | UPS | F | | | | | 344.11 | M02AA21 | tolectin | lok. | 1 | GM | 1,00 | | | | | | | | | | | | 344.12 | M02AA23 | indomethacin | lok. | 1 | GM | 1,00 | | | 96395 | BONIDON | gel 50gm | MHA | CH | | | | | 67408 | INDOBENE | gel 1x50gm | MCK | D | | | | | 67409 | INDOBENE | gel 1x100gm | MCK | D | | | | | 88595 | INDOMETACINOVY GEL 1% GLO | gel 1x50gm | GAO | CZ | | | | | 66959 | VONUM CUTAN | ung 1x75gm | LIC | D | | | | | 345 | M02AC | deriváty kyseliny salicylové k lokálnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 345.1 | M02AC | přípravky s deriváty kyseliny salicylové | lok. | 1 | GM | 1,00 | | | 03574 | RHEUMOSIN | ung 1x30gm | LEX | CZ | | | | | 346 | M02AX | jiná léčiva k léčbě kloubů a svalů k zevnímu podání | lok. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 346.1 | M02AX | jiné přípr. k léč. kloubů a svalů k zevnímu použ. | lok. | 1 | GM | 1,00 | | | 83872 | UNGUENTUM CAMPHORATUM 10% MVM | ung 1x1kg | MVM | CZ | | | | | 83873 | UNGUENTUM CAMPHORATUM 20% MVM | ung 1x1kg | MVM | CZ | | | | | 91114 | VIPROSAL B | ung 1x50gm | TAL | EST | | | | | 91764 | YELLON | gel 1x50gm | SLO | SK | | | | | 346.2 | M02AX10 | různé | lok. | 1 | GM | 0,40 | | | 00803 | PAIN EXPELLER | liq 1x50ml | GNO | CZ | | | | | 00830 | APHLOX | pst 1x200gm | LEX | CZ | | | | | 347 | M03AA | svalová relaxancia ze skupiny kurarových alkaloidů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 347.1 | M03AA01 | alkuronium | parent. | 20 | MG | 65,00 | H | | | | | | | | | | | 347.2 | M03AA02 | tubokurarin | parent. | 30 | MG | 57,10 | H | | 87718 | TUBOCURARIN | inj 25x1.5ml/15mg | ORN | SF | | | | | 348 | M03AB | svalová relaxancia ze skupiny derivativátů cholinu | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 348.1 | M03AB | decamethonium | parent. | 10 | MG | 24,30 | H | | 00577 | PROCURAN | inj 10x2ml/4mg | SPX | CZ | | | | | 348.2 | M03AB01 | suxamethonium (do 100 mg v jedné ampuli včetně) | parent. | 100 | MG | 55,00 | H | | 97386 | SUCCINYLCHOLINJODID VUAB | inj 1x100mg | VUA | CZ | | | | | 348.3 | M03AB01 | suxamethonium (nad 100 mg v jedné ampuli) | parent. | 100 | MG | 31,20 | H | | 97387 | SUCCINYLCHOLINJODID VUAB | inj 1x250mg | VUA | CZ | | | | | 349 | M03AC | svalová relaxancia ze skupiny kvarterních amoniových derivátů | parent. | H | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 349.1 | M03AC01 | pankuronium | parent. | 10 | MG | 116,20 | H | | 02783 | PAVULON 4MG (2ML) | inj 50x2ml/4mg | ORK | NL | | | | | 349.2 | M03AC02 | gallamin | parent. | 100 | MG | 44,10 | H | | | | | | | | | | | 349.3 | M03AC03 | vekuronium | parent. | 10 | MG | 116,20 | H | | 94108 | NORCURON | inj 25x4mg+1ml solv | GED | H | | | | | 349.4 | M03AC04 | atrakurium | parent. | 50 | MG | 147,85 | H | | 86760 | TRACRIUM | inj 5x2.5ml/25mg | BWE | GB | | | | | 86761 | TRACRIUM | inj 5x5ml/50mg | BWE | GB | | | | | 97376 | TRACRIUM | inj 2x25ml/250mg | BWE | GB | | | | | 349.5 | M03AC06 | pipekuronium | parent. | 10 | MG | 105,85 | H | | 350 | M03AX | ostatní svalová relaxancia | parent. | X | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 350.1 | M03AX01 | botulotoxin (do 100 U v jedné ampuli včetně) | parent. | 100 | U | 10350,00 | X | | | | | | | | | | | 350.2 | M03AX01 | botulotoxin (nad 100 U v jedné ampuli) | parent. | 100 | U | 2318,55 | X | | 97456 | DYSPORT | inj sic 2x500ut | SPY | GB | | | | | 351 | M03BX | jiná centrálně působící svalová relaxancia | p.o. | L/NEU,ORT,REV | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 351.1 | M03BX | tetrazepam | p.o. | 0.1 | GM | 15,00 | L/NEU,ORT, REV | | | | | | | | | | | 351.2 | M03BX01 | baklofen (do 10 mg v jedné tabletě včetně) | p.o. | 50 | MG | 10,20 | | | 40274 | BACLOFEN | tbl 50x10mg | POL | PL | | | | | 351.3 | M03BX01 | baklofen (nad 10 mg v jedné tabletě) | p.o. | 50 | MG | 6,45 | | | 40275 | BACLOFEN | tbl 50x25mg | POL | PL | | | | | 351.4 | M03BX02 | tizanidin (do 2 mg v jedné tabletě včetně) | p.o. | 12 | MG | 27,60 | L/NEU,ORT, REV | | 62523 | SIRDALUD | tbl 20x2mg | SAN | CH | | | | | 351.5 | M03BX02 | tizanidin (nad 2 mg v jedné tabletě) | p.o. | 12 | MG | 20,40 | L/NEU,ORT, REV | | 91284 | SIRDALUD | tbl 30x4mg | SAN | CH | | | | | 351.6 | M03BX04 | tolperison | p.o. | 200 | MG | 2,55 | | | | | | | | | | | | 351.7 | M03BX04 | tolperison | parent. | 200 | MG | 8,40 | | | 352 | M03CA | přímo působící svalová relaxancia | parent. | T | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 352.1 | M03CA01 | dantrolen | parent. | 0.1 | GM | 7484,60 | T | | 91583 | DANTROLEN | inj sic 3x12x20mg+solv | RHA | D | | | | | 353 | M04AA | antiuratika inhibující tvorbu kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 353.1 | M04AA01 | allopurinol | p.o. | 0.4 | GM | 3,50 | | | 96332 | ALOPURINOL BELUPO | tbl 100x100mg | BLU | CHO | | | | | 97981 | APO-ALLOPURINOL 100MG | tbl 100x100mg | APT | CND | | | | | 67216 | PURINOL 100MG | tbl 100x100mg | MCK | A | | | | | 67217 | PURINOL 300MG | tbl 30x300mg | MCK | A | | | | | 354 | M04AB | antiuratika zvyšující vylučování kyseliny močové | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 354.1 | M04AB02 | sulfinpyrazon | p.o. | 0.3 | GM | 5,20 | | | | | | | | | | | | 354.2 | M04AB03 | benzbromaron | p.o. | 0.1 | GM | 1,90 | | | 11854 | DESURIC | tbl 60x100mg | SWI | F | | | | | 355 | M04AC | léčiva užívaná při léčbě dnavého záchvatu | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 355.1 | M04AC01 | kolchicin | p.o. | 1 | MG | 5,85 | | | 62380 | COLCHICUM-DISPERT | tbl obd 50x500rg | KCH | D | | | | | 356 | M05BA | bisfosfonáty | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog nebo endokrinolog:

• a) osteoporotické patologické zlomeniny,

• b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),

• c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,

• d) hyperkalcémie provázejícící zhoubné nádory s kostními metastázámi nebo i bez metastáz, mnohočetný myelom.

| 356.1 | M05BA02 | kyselina klodronová | p.o. | 1.6 | GM | 308,90 | P | | 94460 | BONEFOS 400MG | cps 100x400mg | LOY | SF | | | | | 93985 | LODRONAT | cps 60x500mg | BOM | A | | | | | 356.2 | M05BA04 | kyselina alendronová | p.o. | 10 | MG | 54,70 | P | | 84736 | FOSAMAX 10MG | tbl 28x10mg | MSD | I | | | | | 357 | M05BA | bisfosfonáty | parent. | O/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |

Léčbu ordinuje onkolog, hematolog, internista, ortoped, revmatolog nebo endokrinolog:

• a) osteoporotické patologické zlomeniny,

• b) všechny formy osteoporózy (včetně formy sekundární a osteoporózy indukované kortikosteroidy) potvrzené jedno nebo dvouenergetickou rengenovou absorpcimetrií (T-skóre větší než -2,5 SD) nereagující na standardní léčbu (estrogeny, vápník, vitamin D a jeho deriváty, fluor),

• c) Pagetova choroba se sérovou koncentrací alkalické fosfatázy nejméně dvojnásobné než horní hranice normálních hodnot, při bolestech nebo hypercirkulačním syndromu nebo v případě hrozících komplikací,

• d) hyperkalcémie provázejícící zhoubné nádory s kostními metastázámi nebo i bez metastáz, mnohočetný myelom.